US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang

Moderna shares rose ​9% on Wednesday after it settled a long-running legal ​battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing it to focus on its pipeline.